Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

A Comparison of the Effects of Quercetin Hydrate With Those of Vitamin E on the Levels of IL-13, PDGF, TNF-α, and INF-γ in Bleomycin-Induced Pulmonary Fibrosis in Rats

Ali Reza Malayeri 1 , Ali Asghar Hemmati 1 , * , Ardeshir Arzi 2 , Annahita Rezaie 3 , Mehri Ghafurian-Boroojerdnia 4 and Hamid Reza Khalili 1
Authors Information
1 Department of Pharmacology and Toxicology, Medicinal Plants and Natural Products Research Center, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of Pharmacology and Toxicology, Physiology Research Center, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Department of Pathology, Faculty of Veterinary Medicine, Shahid Chamran University, Ahvaz, IR Iran
4 Department of Immunology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: May 01, 2016, 11 (2); e27705
  • Published Online: April 23, 2016
  • Article Type: Research Article
  • Received: February 4, 2015
  • Revised: July 25, 2015
  • Accepted: January 23, 2016
  • DOI: 10.17795/jjnpp-27705

To Cite: Malayeri A R, Hemmati A A, Arzi A, Rezaie A, Ghafurian-Boroojerdnia M, et al. A Comparison of the Effects of Quercetin Hydrate With Those of Vitamin E on the Levels of IL-13, PDGF, TNF-α, and INF-γ in Bleomycin-Induced Pulmonary Fibrosis in Rats, Jundishapur J Nat Pharm Prod. 2016 ; 11(2):e27705. doi: 10.17795/jjnpp-27705.

Abstract
Copyright © 2016, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Arts MJ, Sebastiaan Dallinga J, Haenen GR. A new approach to assess the total antioxidant capacity using the TEAC assay. Food Chem. 2004; 88(4): 567-70[DOI]
  • 2. Wattel A, Kamel S, Prouillet C, Petit JP, Lorget F, Offord E, et al. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1. J Cell Biochem. 2004; 92(2): 285-95[DOI][PubMed]
  • 3. Kim YJ, Bae YC, Suh KT, Jung JS. Quercetin, a flavonoid, inhibits proliferation and increases osteogenic differentiation in human adipose stromal cells. Biochem Pharmacol. 2006; 72(10): 1268-78[DOI][PubMed]
  • 4. Vieira EK, Bona S, Di Naso FC, Porawski M, Tieppo J, Marroni NP. Quercetin treatment ameliorates systemic oxidative stress in cirrhotic rats. ISRN Gastroenterol. 2011; 2011: 604071[DOI][PubMed]
  • 5. Chen X. Protective effects of quercetin on liver injury induced by ethanol. Pharmacogn Mag. 2010; 6(22): 135-41[DOI][PubMed]
  • 6. Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, et al. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr. 2002; 76(3): 560-8[PubMed]
  • 7. Hemmati AA, Rezaie A, Darabpour P. Preventive effects of pomegranate seed extract on bleomycin-induced pulmonary fibrosis in rat. Jundishapur J Nat Pharm Prod. 2013; 8(2): 76-80[PubMed]
  • 8. Richeldi L, Davies HRHR, Spagnolo P, Luppi F, Richeldi L. Corticosteroids for idiopathic pulmonary fibrosis. 2003; [DOI]
  • 9. Chen F, Gong L, Zhang L, Wang H, Qi X, Wu X, et al. Short courses of low dose dexamethasone delay bleomycin-induced lung fibrosis in rats. Eur J Pharmacol. 2006; 536(3): 287-95[DOI][PubMed]
  • 10. Demedts M, Costabel U. ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Eur Respir J. 2002; 19(5): 794-6[PubMed]
  • 11. Kim DS, Collard HR, King TJ. Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc. 2006; 3(4): 285-92[DOI][PubMed]
  • 12. Kuwano K, Kunitake R, Maeyama T, Hagimoto N, Kawasaki M, Matsuba T, et al. Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol. 2001; 280(2)-25[PubMed]
  • 13. Adamson IY. Pulmonary toxicity of bleomycin. Environ Health Perspect. 1976; 16: 119-26[PubMed]
  • 14. Umezawa H, Ishizuka M, Maeda K, Takeuchi T. Studies on bleomycin. Cancer. 1967; 20(5): 891-5
  • 15. Sleijfer S. Bleomycin-induced pneumonitis. CHEST J. 2001; 120(2): 617-24
  • 16. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994; 331(19): 1286-92[DOI][PubMed]
  • 17. Abdollahi A, Li M, Ping G, Plathow C, Domhan S, Kiessling F, et al. Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med. 2005; 201(6): 925-35[DOI][PubMed]
  • 18. Aliprantis AO, Wang J, Fathman JW, Lemaire R, Dorfman DM, Lafyatis R, et al. Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13. Proc Natl Acad Sci U S A. 2007; 104(8): 2827-30[DOI][PubMed]
  • 19. Hasegawa M, Fujimoto M, Kikuchi K, Takehara K. Elevated serum tumor necrosis factor-alpha levels in patients with systemic sclerosis: association with pulmonary fibrosis. J Rheumatol. 1997; 24(4): 663-5[PubMed]
  • 20. Moutsatsou P. The spectrum of phytoestrogens in nature: our knowledge is expanding. Hormones (Athens). 2007; 6(3): 173-93[PubMed]
  • 21. Cortijo J, Cerda-Nicolas M, Serrano A, Bioque G, Estrela JM, Santangelo F, et al. Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats. Eur Respir J. 2001; 17(6): 1228-35[PubMed]
  • 22. Wang HD, Yamaya M, Okinaga S, Jia YX, Kamanaka M, Takahashi H, et al. Bilirubin ameliorates bleomycin-induced pulmonary fibrosis in rats. Am J Respir Crit Care Med. 2002; 165(3): 406-11[DOI][PubMed]
  • 23. Kilinc C, Ozcan O, Karaoz E, Sunguroglu K, Kutluay T, Karaca L. Vitamin E reduces bleomycin-induced lung fibrosis in mice: biochemical and morphological studies. J Basic Clin Physiol Pharmacol. 1993; 4(3): 249-69[PubMed]
  • 24. Daba MH, Abdel-Aziz AA, Moustafa AM, Al-Majed AA, Al-Shabanah OA, El-Kashef HA. Effects of L-carnitine and ginkgo biloba extract (EG b 761) in experimental bleomycin-induced lung fibrosis. Pharmacol Res. 2002; 45(6): 461-7[PubMed]
  • 25. Larki-Harchegani A, Hemmati AA, Arzi A, Ghafurian-Boroojerdnia M, Shabib S, Zadkarami MR, et al. Evaluation of the Effects of Caffeic Acid Phenethyl Ester on Prostaglandin E2 and Two Key Cytokines Involved in Bleomycin-induced Pulmonary Fibrosis. Iran J Basic Med Sci. 2013; 16(7): 850-7[PubMed]
  • 26. Schraufnagel DE, Mehta D, Harshbarger R, Treviranus K, Wang NS. Capillary remodeling in bleomycin-induced pulmonary fibrosis. Am J Pathol. 1986; 125(1): 97-106[PubMed]
  • 27. Giri SN, Hyde DM, Nakashima JM. Analysis of bronchoalveolar lavage fluid from bleomycin-induced pulmonary fibrosis in hamsters. Toxicol Pathol. 1986; 14(2): 149-57[PubMed]
  • 28. Fell CD, Martinez FJ, Liu LX, Murray S, Han MK, Kazerooni EA, et al. Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2010; 181(8): 832-7[DOI][PubMed]
  • 29. Vyalov SL, Gabbiani G, Kapanci Y. Rat alveolar myofibroblasts acquire alpha-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis. Am J Pathol. 1993; 143(6): 1754-65[PubMed]
  • 30. Costabel U, King TE. International consensus statement on idiopathic pulmonary fibrosis. Eur Respir J. 2001; 17(2): 163-7[PubMed]
  • 31. Gogali A, Wells AU. New pharmacological strategies for the treatment of pulmonary fibrosis. Ther Adv Respir Dis. 2010; 4(6): 353-66[DOI][PubMed]
  • 32. Chiaramonte MG, Cheever AW, Malley JD, Donaldson DD, Wynn TA. Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis. Hepatology. 2001; 34(2): 273-82[DOI][PubMed]
  • 33. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest. 1999; 103(6): 779-88[DOI][PubMed]
  • 34. Raghu G, Brown KK, Costabel U, Cottin V, du Bois RM, Lasky JA, et al. Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. Am J Respir Crit Care Med. 2008; 178(9): 948-55[DOI][PubMed]
  • 35. Ziesche R, Hofbauer E, Wittmann K, Petkov V, Block LH. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 1999; 341(17): 1264-9[DOI][PubMed]
  • 36. Tulek B, Kiyan E, Toy H, Kiyici A, Narin C, Suerdem M. Anti-inflammatory and anti-fibrotic effects of sirolimus on bleomycin-induced pulmonary fibrosis in rats. Clin Invest Med. 2011; 34(6)[PubMed]
  • 37. Zhou C, Han W, Zhang P, Cai M, Wei D, Zhang C. Lycopene from tomatoes partially alleviates the bleomycin-induced experimental pulmonary fibrosis in rats. Nutr Res. 2008; 28(2): 122-30[DOI][PubMed]
  • 38. Tulek B, Kiyan E, Kiyici A, Toy H, Bariskaner H, Suerdem M. Effects of simvastatin on bleomycin-induced pulmonary fibrosis in female rats. Biol Res. 2012; 45(4): 345-50[DOI][PubMed]
  • 39. Bjeldanes LF, Chang GW. Mutagenic activity of quercetin and related compounds. Science. 1977; 197(4303): 577-8[PubMed]
  • 40. Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol. 2008; 585(2-3): 325-37[DOI][PubMed]
  • 41. Haenen GR, Bast A. Nitric oxide radical scavenging of flavonoids. Methods Enzymol. 1999; 301: 490-503[PubMed]
  • 42. Baowen Q, Yulin Z, Xin W, Wenjing X, Hao Z, Zhizhi C, et al. A further investigation concerning correlation between anti-fibrotic effect of liposomal quercetin and inflammatory cytokines in pulmonary fibrosis. Eur J Pharmacol. 2010; 642(1-3): 134-9[DOI][PubMed]
  • 43. Park HK, Kim SJ, Kwon do Y, Park JH, Kim YC. Protective effect of quercetin against paraquat-induced lung injury in rats. Life Sci. 2010; 87(5-6): 181-6[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments